Back to Journals » Drug Design, Development and Therapy » Volume 11

Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models

Total article views   Abstract views HTML views PDF downloads Totals
16,675 Dovepress* 9,095 3,039+ 1,175 12,134
PubMed Central* 0 4,541 340 4,541
Totals 9,095 7,580 1,515 16,675
*Since 11 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar